Filing Details
Progyny, Inc. (NASDAQ:PGNY) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:PGNY
Progyny, Inc. (PGNY) Files Quarterly Report for Q0
Progyny, Inc. (NASDAQ:PGNY) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
Progyny, Inc. (NASDAQ:PGNY) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Progyny, Inc. filed its quarterly report (Form 10-Q) with the SEC on August 07, 2026.
- The company's stock trades at $28.10 with a market capitalization of $2.2 billion.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Progyny, Inc.'s stock currently trades at $28.10 with a market capitalization of $2.2B.
The 10-Q provides Progyny, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Progyny, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PGNY Stock Page
Frequently Asked Questions
Where can I read PGNY's SEC filings?
Browse all filings on our PGNY SEC filings page.
What types of SEC filings does Progyny, Inc. file?
Public companies like Progyny, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.